Axogen, Inc. — Investor Relations & Filings
Filings indexed
1,140
across all filing types
Latest filing
2026-04-29
Annual Report
Country
US
United States of America
Listing
US
AXGN
Axogen, Inc. is a regenerative medicine company focused on developing and commercializing surgical solutions for peripheral nerve repair. The company provides technologies designed to restore sensation and functionality to individuals with damaged peripheral nerves. Its portfolio is centered on products that facilitate nerve regeneration and repair, such as the Avance® Nerve Graft, a processed human nerve allograft for bridging nerve gaps. Axogen's solutions are utilized by surgeons to treat patients with nerve injuries resulting from trauma or other medical conditions, aiming to improve their quality of life by restoring function and reducing pain.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Axogen, Inc. (0000805928) (Filer) | 2026-04-29 | English | |
| 10-Q - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | |
| 8-K - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38812505 | ARS - Axogen, Inc. (0000805928) (Filer) | 2026-04-29 | English | ||
| 38156020 | 10-Q - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | ||
| 37961677 | 8-K - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | ||
| 32881519 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881520 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881521 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881522 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-27 | English | ||
| 32881523 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-27 | English | ||
| 32881524 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 32881526 | 10-K - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 32881525 | 8-K - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 18776430 | 8-K Filing | 2026-01-23 | English | ||
| 18776423 | 424B5 Filing | 2026-01-23 | English | ||
| 18776405 | 424B5 Filing | 2026-01-21 | English | ||
| 18776372 | S-3ASR Filing | 2026-01-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioLineRx Ltd.
A clinical-stage biopharmaceutical company developing thera…
|
BLRX | IL | Manufacturing |
|
BIOMARIN PHARMACEUTICAL INC
A global biotechnology company developing therapies for rar…
|
BMRN | US | Manufacturing |
|
BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for cl…
|
BMX | PL | Manufacturing |
|
Biomea Fusion, Inc.
A clinical-stage biopharma developing oral drugs for diabet…
|
BMEA | US | Manufacturing |
|
BIOME AUSTRALIA LIMITED
Develops and distributes evidence-based probiotics and comp…
|
BIO | AU | Manufacturing |
|
Biome Grow Inc.
Production and distribution of cannabis products focused on…
|
BIO | CA | Manufacturing |
|
BIOMERICA INC
Develops in-vitro diagnostic and therapeutic products for c…
|
BMRA | US | Manufacturing |
|
bioMérieux
A global leader in in vitro diagnostics for clinical and in…
|
BIM | FR | Manufacturing |
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
Axogen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32414/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32414 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32414 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32414 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32414}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Axogen, Inc. (id: 32414)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.